Kissei Pharmaceutical Co., Ltd.: all 63 studies

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Trial of Olutasidenib in Patients With Acute Myeloid LeukemiaRecruitingNCT07604064Phase 2
• Special Drug Use-results Survey for Long-term Use（Avacopan）RecruitingNCT06758271
• Special Drug Use-results Survey for Long-term Use (Fostamatinib)RecruitingNCT06757257
• A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.CompletedNCT04711603Phase 3Results posted
• Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated PainTerminatedNCT04372121Phase 3Results posted
• Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)CompletedNCT04335591Phase 3Results posted
• A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788CompletedNCT04132050Phase 3Results posted
• Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.CompletedNCT03992846Phase 3Results posted
• A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated PainTerminatedNCT03986944Phase 3Results posted
• A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.CompletedNCT03802617Phase 2Results posted
• Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes MellitusCompletedNCT02154347Phase 4Results posted
• A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850641Phase 3Results posted
• A Phase III Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850602Phase 3Results posted
• A Long-term Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01833494Phase 3Results posted
• A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer AgentsCompletedNCT01596088Phase 1/2Results posted
• PA21 Phase II Clinical Study in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01521494Phase 2Results posted
• Long-term Study of KAD-1229 in Type 2 Diabetes PatientsCompletedNCT01333592Phase 3Results posted
• Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar DegenerationActive, not recruitingNCT07040137Phase 3
• A Clinical Study of KLH-2109 in Patients With EndometriosisActive, not recruitingNCT07015268Phase 3
• A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseCompletedNCT06722729Phase 2
• An Early Phase 2 Clinical Study of KSP-0243CompletedNCT05831670Phase 2
• A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and PainCompletedNCT05445167Phase 3
• A Clinical Study of KLH-2109 in Uterine Fibroids Patient With MenorrhagiaCompletedNCT05440383Phase 3
• A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseCompletedNCT04867551Phase 2
• A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.CompletedNCT03845387Phase 2
• Clinical Study of YS110 in Patients With Malignant Pleural MesotheliomaCompletedNCT03177668Phase 1/2
• Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseCompletedNCT03068481Phase 1
• A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)CompletedNCT02912533Phase 3
• A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)CompletedNCT02912494Phase 3
• An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT02889302Phase 3
• Late Phase II Clinical Study of KLH-2109 in Patients With EndometriosisCompletedNCT02778919Phase 2
• A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503189Phase 3
• An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeTerminatedNCT02503176Phase 3
• A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503163Phase 3
• Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male SubjectsCompletedNCT02434835Phase 1
• Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedNCT02343978Phase 2
• Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedNCT02281630Phase 2
• Phase II Exploratory Clinical Study of KUX-1151CompletedNCT02190786Phase 2
• A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970137Phase 3
• A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970124Phase 3
• An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970111Phase 3
• A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970098Phase 3
• A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic ConstipationCompletedNCT01938196Phase 2
• A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic ConstipationCompletedNCT01937663Phase 2
• A Late Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01890941Phase 2
• A Phase III Study of PA21 in Peritoneal Dialysis Patients With HyperphosphatemiaCompletedNCT01852682Phase 3
• A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01692145Phase 2
• A Phase II Randomized Open Label Study of KLH-2109 in Patients With EndometriosisCompletedNCT01629420Phase 2
• A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)CompletedNCT01600001Phase 2
• A Dose-finding Study of Silodosin in Patients With Urinary CalculiCompletedNCT01539265Phase 2
• A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)CompletedNCT01533532Phase 2
• A Phase II Study of KCT-0809 in Patients With Dry Eye SyndromeCompletedNCT01427816Phase 2
• A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)CompletedNCT01395940Phase 2
• A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01384435Phase 2
• A Comparative Study of KSO-0400 in BPH Patients With LUTSCompletedNCT01222650Phase 2
• A Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01211951Phase 2
• A Confirmatory Study of KUC-7483 in Patients With Overactive BladderCompletedNCT01004315Phase 3
• A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01004016Phase 2
• Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive BladderWithdrawnNCT01003405Phase 3
• Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT00863538Phase 2
• A Phase II Study of KUC-7483 in Patients With Overactive BladderCompletedNCT00742833Phase 2
• Phase 2 Study of KLS-0611 in Patients With Dry Eye SyndromesCompletedNCT00721656Phase 2
• Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic PatientsCompletedNCT00461617Phase 3

← Kissei Pharmaceutical Co., Ltd. overview and focus areas